Charles River Laboratories International (CRL) Current Assets (2009 - 2026)

Charles River Laboratories International has reported Current Assets for 18 years, with the latest figure at $1.5 billion in Q2 2026.

• On a quarterly basis, Current Assets rose 4.03% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 4.03% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 3.13% from the prior year.
• Current Assets was $1.5 billion for Q2 2026 at Charles River Laboratories International, up from $1.5 billion in the prior quarter.
• The five-year high for Current Assets was $1.7 billion in Q1 2024, with the low at $1.3 billion in Q1 2022.
• Average Current Assets over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2025.
• The largest YoY upside for Current Assets was 15.18% in 2024 against a maximum downside of 12.78% in 2024.
• Over 5 years, Current Assets stood at $1.4 billion in 2022, then climbed by 11.79% to $1.6 billion in 2023, then decreased by 12.78% to $1.4 billion in 2024, then grew by 3.13% to $1.4 billion in 2025, then increased by 5.67% to $1.5 billion in 2026.
• The last three Current Assets figures came in at $1.5 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.